Daxxify costs about $8 to $25 per unit, most often $8 to $15, or roughly $400 to $800 for a standard 40-unit frown-line session. See per-unit and per-vial prices, what drives cost, how it compares to Botox, and how to budget and find a qualified provider.
Daxxify typically costs about $8 to $25 per unit in the U.S., most commonly $8 to $15, which works out to roughly $400 to $800 for a standard 40-unit frown-line session. A 100-unit vial averages around $400 to $700. Prices are ranges, not quotes; your injector confirms cost after assessing you.
Prices below are national ranges published for education. They are not quotes, offers, or guarantees, and your actual price is confirmed by a licensed provider after an in-person assessment.
Regulatory note: Daxxify (daxibotulinumtoxinA-lanm, made by Revance) is FDA-approved only for the temporary improvement of moderate to severe glabellar, or frown, lines in adults, and separately for cervical dystonia. Using it on the forehead, around the eyes, or in the jaw is off-label, though injectors commonly do so. Cost varies with dose, provider, and where you live.
Daxxify is priced per unit, the same way Botox and other neurotoxins are. Across U.S. medspas and dermatology practices, per-unit prices generally land between about $8 and $25, with most real-world pricing clustering around $8 to $15 per unit. Because dosing is what drives the total, the more useful number is the per-session cost. A standard glabellar (frown line) treatment used about 40 units in the FDA trials, which at typical per-unit rates works out to roughly $400 to $800 per session. A smaller touch-up on a single area may run $150 to $400, while broader multi-area upper-face treatments can reach $800 to $1,200 or more.
Separately, the drug itself has a wholesale and pharmacy price. A single 100-unit vial averages around $500 cash, with discount programs and coupons bringing it closer to $400 to $432. Patients rarely pay the vial price directly, because clinics buy the vial, reconstitute it, and bill you for the units injected plus their service. Some practices instead quote a flat per-area price. Every figure here is a national range for education, not a quote. Your actual cost depends on your dose, your market, and your injector, and can only be confirmed at a consultation.
| Cost basis | Typical range* | Notes |
|---|---|---|
| Per unit | $8 to $25 (most $8 to $15) | Units are not comparable across brands |
| Standard frown-line session (about 40 units) | $400 to $800 | FDA-trial reference dose |
| Single small-area touch-up (about 10 to 20 units) | $150 to $400 | Less product used |
| Multi-area upper face | $800 to $1,200+ | Frown lines plus off-label forehead and crow's feet |
| 100-unit vial (clinic wholesale or pharmacy cash) | about $400 to $700 | Clinic buys the vial, bills you per unit used |
*Ranges only, for education. Actual price depends on your dose, region, and injector. Not a quote.
Your Daxxify bill is not just the cost of the toxin. It bundles several things. First, the product itself: Daxxify is a newer, patented formulation of daxibotulinumtoxinA-lanm stabilized with a proprietary peptide instead of human serum albumin, and as a branded, recently launched neurotoxin its acquisition cost to clinics can sit at or above older toxins. Second, injector expertise: a board-certified dermatologist, plastic surgeon, or an experienced nurse or physician-assistant injector working under physician oversight charges for skill, judgment, and safety, not just for pushing a syringe. Precise muscle targeting is what separates a natural result from a frozen or asymmetric one.
Third, the consultation and assessment, where a qualified provider evaluates your anatomy, medical history, and goals and decides whether Daxxify, another toxin, or a different treatment fits you. Fourth, the facility and overhead: a licensed medical setting, sterile single-use supplies, and clean technique. Fifth, follow-up, since reputable clinics include or offer a roughly two-week check and a touch-up policy. When a price looks dramatically below the local market, ask what is being trimmed, whether that is dilution, injector credentials, or follow-up. Cheap toxin injected poorly is not a bargain. You are paying for a medical service, and the quality of that service is where most of the value sits.
Several variables move the final number up or down. Dose is the biggest: stronger or larger muscles, deeper lines, and treating more than one area all raise the unit count and therefore the price. Geography matters, because major metro markets such as New York, Los Angeles, and Miami typically price above smaller cities and rural areas. Injector credentials and reputation factor in too, as a highly sought physician injector often charges more per unit than a high-volume discount chain, and that premium frequently buys better technique and safer complication management.
The pricing model changes what you see. Per-unit pricing is the most transparent, because you can verify the dose you receive, while per-area or flat-package pricing can obscure whether you are getting a full, effective dose. Ask which model the clinic uses and how many units are included. Promotions and loyalty programs can legitimately lower cost, and Revance has run patient savings offers that some clinics pass along. Product dilution is a hidden factor, because over-diluting a vial stretches the clinic's supply but can weaken or shorten your result, so a suspiciously cheap per-unit price can mean fewer effective units. First treatments sometimes cost more than maintenance visits, and conversely some clinics run new-patient specials. Because Daxxify is dosed to your individual anatomy rather than a flat number, two people treating the same frown lines can pay different amounts, and only an in-person assessment produces an accurate quote.
Understanding units helps you read a quote. In the FDA pivotal trials the standard glabellar dose was 40 units delivered across five injection points, so 40 units is the reference dose for frown lines, and at common per-unit pricing that lands around $400 to $800. A lighter dose of about 20 units may be used for a subtle effect or a smaller, less muscular area, but for classic moderate to severe frown lines 20 units is often on the low side and may fade faster. Whether it is enough depends on your muscle strength and goals, which is a judgment your injector makes rather than a fixed rule.
A full 100-unit vial is enough to treat multiple areas or two people in one session. At retail per-unit prices, 100 injected units corresponds to roughly $800 to $2,000, although the vial's own wholesale cost is far lower. A key caution: Daxxify units are not interchangeable with Botox, Dysport, Xeomin, or Jeuveau units. Each product has its own potency and its own unit scale, so comparing raw unit counts or raw per-unit prices between brands is misleading. The only fair comparison is cost per treated area over the time the result actually lasts.
On a pure per-unit basis, Daxxify often looks similar to or slightly higher than Botox, but per-unit price is the wrong lens. The headline reason people consider Daxxify is duration. In clinical trials the median time before frown lines returned to moderate or severe was about 24 weeks, roughly six months, compared with the three to four months typical of Botox and other toxins. If that longer duration holds for you, you may need fewer sessions per year, which can offset a higher per-visit cost. Two Daxxify sessions a year could rival three to four Botox sessions on total annual spend, while cutting the number of appointments and needle visits.
The honest caveat is that trial medians are averages, and real-world duration varies widely. Many patients report Daxxify lasting closer to four to five months rather than a full six, and individual results depend on dose, area, metabolism, and muscle activity. Some people also simply respond better to one toxin than another. Botox, Dysport, Xeomin, and Jeuveau remain effective, well-established, and often cheaper per visit. Botox is FDA-approved for frown lines, forehead lines, and crow's feet, while Daxxify is FDA-approved only for frown lines, so using it on the forehead or around the eyes is off-label even though injectors commonly do so. The right choice is not automatically the longest-lasting or the cheapest option; it is the toxin and injector that give you a natural, safe result at a cost you can sustain.
Whether Daxxify is worth it depends on what you value. If minimizing the number of visits matters to you, whether for convenience, travel, or needle anxiety, and Daxxify's longer duration holds for your muscles, the higher per-session price can be worthwhile because you go less often. For people who have found other toxins fade quickly, a longer-lasting option can also feel like better value even at a similar annual cost. On the other hand, if you already respond well to a cheaper toxin, are new to neurotoxins and want to start conservatively, or want the flexibility to adjust your look every few months, a shorter-acting product may suit you better and cost less per visit.
Value is not the lowest sticker price; it is the right dose, placed well, lasting as expected, for a total annual cost you can maintain. An underdosed bargain that fades in six weeks costs more over a year than a properly dosed treatment. Because Daxxify's real-world longevity varies and results are never guaranteed, it is reasonable to treat your first round as a test: judge value after you see how long your own result actually lasts, then decide whether to continue. No honest provider promises a specific duration in advance.
Start budgeting from the per-session number, not the per-unit number, because dose is what you actually pay for. For frown lines, plan for roughly $400 to $800 per session, and estimate your annual cost from how often you realistically return. At two sessions a year that is about $800 to $1,600. Ask every clinic three questions: do you price per unit or per area, how many units is my recommended dose, and is a two-week touch-up included. Transparent per-unit pricing with a clearly stated dose is the easiest to verify and compare. Be wary of prices far below the local norm, which can signal over-dilution, an inexperienced injector, or counterfeit product.
Choose your injector on credentials and technique first, and price second. Look for a board-certified dermatologist or plastic surgeon, or a licensed nurse or physician-assistant injector working under physician supervision, with real before-and-after photos and strong reviews. A good consultation should feel like a medical assessment, not a sales pitch, and a reputable provider will tell you when a different toxin or a non-injectable option fits you better. Manufacturer savings programs and clinic loyalty rewards can trim cost legitimately, so ask what is available. When you are ready to compare qualified, verified injectors near you and see who offers Daxxify, use the provider directory to hand off to a licensed clinic and confirm your exact price at an in-person consultation.
Forty units is the standard glabellar, or frown-line, dose used in Daxxify's FDA trials. At typical per-unit pricing of about $8 to $15, that works out to roughly $400 to $800 per session, though premium or major-metro practices can charge more. The exact figure depends on your market and injector and is confirmed at consultation.
Not usually per visit. Daxxify's per-unit price is similar to or slightly above Botox, and units are not interchangeable between brands. Its appeal is duration: trials showed a median of about six months versus three to four for Botox. If that holds for you, fewer sessions per year may narrow the annual cost gap.
A 100-unit vial is enough to treat multiple areas or two patients. At retail per-unit pricing, 100 injected units corresponds to roughly $800 to $2,000, though the vial's wholesale cost is far lower, averaging around $400 to $500 cash before discounts. You pay for the units used, not the whole vial, unless the full dose is injected.
In FDA trials the median time before frown lines returned was about 24 weeks, roughly six months, longer than the three to four months typical of Botox. Real-world results vary widely, and many patients report closer to four to five months. Duration depends on dose, muscle strength, and metabolism, and results are never guaranteed.
Daxxify's real-world duration varies and may fall short of the six-month trial median. It is FDA-approved only for frown lines, so forehead and crow's feet use is off-label. Side effects mirror other toxins: headache, eyelid or brow drooping, and injection-site reactions. It is also newer and often priced at or above established alternatives.